Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage

Kevin N. Sheth(Yale University), Jeffrey L. Saver(Comprehensive Clinical Research), Deepak L. Bhatt(Brigham and Women's Hospital), Brooke Alhanti(Clinical Research Institute), Eric E. Smith(University of Calgary), Nicole Solomon(Duke University), Ying Xian, Ilya Danelich(AstraZeneca (United States)), Brian Mac Grory(Duke University), Joshua N. Goldstein, Jennifer Frontera(Norwegian Womens Public Health Association), Gregg C. Fonarow, Raymond Chuen‐Chung Chang(University of Hong Kong), Lee H. Schwamm(Yale University), Steven R. Messé(University of Pennsylvania), Joanna Huang(AstraZeneca (United States)), J. Claude Hemphill
JAMA Neurology
February 9, 2024
10.1001/jamaneurol.2024.0221
Cited by 81

Related Papers

Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
|Stroke|2019|7.2k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
|New England Journal of Medicine|2015|6k
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
|New England Journal of Medicine|2017|5.5k
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
|Stroke|2018|5.5k